Quick Answer
Artiva Biotherapeutics, Inc. reported Total Assets of $130.94 million for fiscal year 2025.
Artiva Biotherapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $130.94M | -37.5% |
| 2024 | $209.58M | +99.4% |
| 2023 | $105.11M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $148.86M | -34.0% | -12.1% |
| June 30, 2025 | $169.39M | +123.1% | -11.4% |
| March 31, 2025 | $191.26M | — | -8.7% |
| December 31, 2024 | $209.58M | +99.4% | -7.1% |
| September 30, 2024 | $225.60M | — | +197.2% |
| June 30, 2024 | $75.91M | — | -27.8% |
| December 31, 2023 | $105.11M | — | — |
- Artiva Biotherapeutics, Inc. showed a decrease of -37.5% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Artiva Biotherapeutics, Inc.’s total assets has grown by 24.6% (from $105.11 million to $130.94 million).
- The most recent figure is from Artiva Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: